Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
JAMA Netw Open. 2019 Feb 1;2(2):e187571. doi: 10.1001/jamanetworkopen.2018.7571.
Sepsis is present in many hospitalizations that culminate in death. The contribution of sepsis to these deaths, and the extent to which they are preventable, is unknown.
To estimate the prevalence, underlying causes, and preventability of sepsis-associated mortality in acute care hospitals.
DESIGN, SETTING, AND PARTICIPANTS: Cohort study in which a retrospective medical record review was conducted of 568 randomly selected adults admitted to 6 US academic and community hospitals from January 1, 2014, to December 31, 2015, who died in the hospital or were discharged to hospice and not readmitted. Medical records were reviewed from January 1, 2017, to March 31, 2018.
Clinicians reviewed cases for sepsis during hospitalization using Sepsis-3 criteria, hospice-qualifying criteria on admission, immediate and underlying causes of death, and suboptimal sepsis-related care such as inappropriate or delayed antibiotics, inadequate source control, or other medical errors. The preventability of each sepsis-associated death was rated on a 6-point Likert scale.
The study cohort included 568 patients (289 [50.9%] men; mean [SD] age, 70.5 [16.1] years) who died in the hospital or were discharged to hospice. Sepsis was present in 300 hospitalizations (52.8%; 95% CI, 48.6%-57.0%) and was the immediate cause of death in 198 cases (34.9%; 95% CI, 30.9%-38.9%). The next most common immediate causes of death were progressive cancer (92 [16.2%]) and heart failure (39 [6.9%]). The most common underlying causes of death in patients with sepsis were solid cancer (63 of 300 [21.0%]), chronic heart disease (46 of 300 [15.3%]), hematologic cancer (31 of 300 [10.3%]), dementia (29 of 300 [9.7%]), and chronic lung disease (27 of 300 [9.0%]). Hospice-qualifying conditions were present on admission in 121 of 300 sepsis-associated deaths (40.3%; 95% CI 34.7%-46.1%), most commonly end-stage cancer. Suboptimal care, most commonly delays in antibiotics, was identified in 68 of 300 sepsis-associated deaths (22.7%). However, only 11 sepsis-associated deaths (3.7%) were judged definitely or moderately likely preventable; another 25 sepsis-associated deaths (8.3%) were considered possibly preventable.
In this cohort from 6 US hospitals, sepsis was the most common immediate cause of death. However, most underlying causes of death were related to severe chronic comorbidities and most sepsis-associated deaths were unlikely to be preventable through better hospital-based care. Further innovations in the prevention and care of underlying conditions may be necessary before a major reduction in sepsis-associated deaths can be achieved.
脓毒症存在于许多最终导致死亡的住院治疗中。脓毒症对这些死亡的贡献,以及它们在多大程度上是可以预防的,目前尚不清楚。
估计急性护理医院中脓毒症相关死亡率的患病率、根本原因和可预防性。
设计、地点和参与者:本队列研究回顾性分析了 2014 年 1 月 1 日至 2015 年 12 月 31 日期间入住美国 6 所学术和社区医院的 568 名随机选择的成年人的病历,这些成年人在医院死亡或出院至临终关怀且未再次入院。病历于 2017 年 1 月 1 日至 2018 年 3 月 31 日进行回顾。
临床医生使用 Sepsis-3 标准在住院期间对病例进行脓毒症评估,入院时符合临终关怀标准,评估直接和根本死因以及与脓毒症相关的护理不足,如抗生素使用不当或延迟、不充分的源头控制或其他医疗错误。根据 6 分李克特量表对每例脓毒症相关死亡的可预防性进行评分。
本研究队列包括 568 名患者(289 名[50.9%]男性;平均[SD]年龄,70.5[16.1]岁),他们在医院死亡或出院至临终关怀。300 例住院治疗中存在脓毒症(52.8%;95%CI,48.6%-57.0%),198 例(34.9%;95%CI,30.9%-38.9%)为直接死亡原因。下一个最常见的直接死亡原因是进展性癌症(92 例[16.2%])和心力衰竭(39 例[6.9%])。脓毒症患者最常见的根本死因是实体癌(63 例[21.0%])、慢性心脏病(46 例[15.3%])、血液系统癌症(31 例[10.3%])、痴呆(29 例[9.7%])和慢性肺病(27 例[9.0%])。121 例(300 例中的 40.3%;95%CI,34.7%-46.1%)符合临终关怀标准,最常见的是终末期癌症。在 300 例脓毒症相关死亡中,有 68 例(22.7%)发现护理不足,最常见的是抗生素延迟使用。然而,只有 11 例(3.7%)脓毒症相关死亡被判定为绝对或中度可预防;另有 25 例(8.3%)脓毒症相关死亡被认为可能可预防。
在这项来自美国 6 家医院的队列研究中,脓毒症是最常见的直接死亡原因。然而,大多数根本死因与严重的慢性合并症有关,大多数脓毒症相关死亡不太可能通过更好的医院护理来预防。在脓毒症相关死亡人数大幅减少之前,可能需要在预防和治疗潜在疾病方面进行进一步创新。